Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Precision Medication Guidance Model for Schizophrenia Based on Pharmacogenomics and Physiologically Based Pharmacokinetics: a Real-World Observational Study

NCT06700967 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT06700967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Precision Medication Guidance Model for Schizophrenia Based on Pharmacogenomics and Physiologically Based Pharmacokinetics: a Real-World Observational Study
Lead sponsor
Shanghai Mental Health Center
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 31, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophenia disorder